Provided by Tiger Trade Technology Pte. Ltd.

Celldex Therapeutics

36.90
-1.2000-3.15%
Post-market: 36.900.00000.00%16:15 EDT
Volume:1.03M
Turnover:38.61M
Market Cap:2.90B
PE:-8.50
High:38.59
Open:38.39
Low:36.84
Close:38.10
52wk High:45.14
52wk Low:22.10
Shares:78.49M
Float Shares:73.02M
Volume Ratio:1.61
T/O Rate:1.41%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.3401
EPS(LYR):-3.9000
ROE:-43.88%
ROA:-27.62%
PB:4.05
PE(LYR):-9.46

Loading ...

Analysts Are Bullish on These Healthcare Stocks: Immunic (IMUX), Celldex (CLDX)

TIPRANKS
·
Sep 10

Celldex Therapeutics Inc : Morgan Stanley Raises Target Price to $50.00 from $46.00

THOMSON REUTERS
·
Sep 10

U.S. Research Roundup-Caseys General Stores, Targa Resources, United Rentals

Reuters
·
Sep 10

Celldex Management to Join Cantor Global Healthcare Conference Fireside Chat

Reuters
·
Sep 09

Celldex Posts Investor Presentation Highlighting Barzolvolimab Late-Stage Chronic Urticaria Program Milestones

Reuters
·
Aug 15

Celldex Therapeutics (CLDX) Reported Wider Losses, Is It Still Undervalued?

Simply Wall St.
·
Aug 12

Celldex (CLDX) Gets a Buy from Jefferies

TIPRANKS
·
Aug 08

Celldex Therapeutics is Maintained at Overweight by Morgan Stanley

Dow Jones
·
Aug 08

Analysts Offer Insights on Healthcare Companies: Zoetis (ZTS) and Celldex (CLDX)

TIPRANKS
·
Aug 08

Celldex price target raised to $46 from $40 at Morgan Stanley

TIPRANKS
·
Aug 07

Celldex Therapeutics Q2 EPS $(0.94) Beats $(1.07) Estimate, Sales $22.000K Miss $954.444K Estimate

Benzinga Earnings
·
Aug 07

Celldex Therapeutics, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 07

Celldex Q2 FY26 Net Loss Widens to $73.5 Million; R&D Expenses Climb to $67.5 Million

Reuters
·
Aug 07

Celldex Therapeutics Q2 Revenue USD 22 Thousand

THOMSON REUTERS
·
Aug 07

Celldex Therapeutics (CLDX) After Phase 2 Trial Results As Valuation Questions Come Into Focus

Simply Wall St.
·
Aug 01

PharmaCyte Net Loss Widens to $19.42 Million in FY26; Revenue Remains no Revenue

Reuters
·
Jul 30

U.S. Research ROUNDUP-Boeing, Coca-Cola, PayPal

Reuters
·
Jul 29

Analysts Offer Insights on Healthcare Companies: Alkermes (ALKS) and Celldex (CLDX)

TIPRANKS
·
Jul 25

U.S. Stocks on the Move-ge Vernova, Arrowhead Pharma

Reuters
·
Jul 22

Celldex Therapeutics Shares Down 2.6% After Scrapping Development of Skin Disease Drug

THOMSON REUTERS
·
Jul 22